Adaptive Approach to Naltrexone Treatment for Alcoholism
Naltrexone (NTX) is an opioid receptor antagonist used to prevent alcoholism relapse. This trial examines how to define “non-response” to treatment with NTX and what treatments are most effective for those who do or do not respond to the initial treatment.
Principal Investigator(s): David Oslin
Location: University of Pennsylvania
Funding: NIAAA Project R01AA017164
View all Case Studies HERE.
LET’S STAY IN TOUCH
Join the d3center Mailing List
Keep up to date with the latest news, events, software releases, learning modules, and resources from the d3center.